Wuhan Saili Si Medical Technology Co.

Thalys Medical Technology Group Corporation (so called Thalys Group) is an enterprise with long history and solid experiences in the integrated operation and services of hospital IVD laboratories. Established in 1998 at Tianjin city and became a public company (Stock Code: 603716.SH) listed in the main stock board at Shanghai Stock Exchange (SSE) since 2016. Thalys Group aspires to be the most innovative and trusted partner of China healthcare system by building upon our expertise, scale and intelligence in distribution, solutions and services. Thalys Group focus on what matters most to lives, medical practitioners and partners. Its nationwide IVD consolidation in distribution & service network covers more than 30 provinces & 2,000 cities, supplying to more than 1,000 hospitals and 300 hospital IVD labs, and partnering with 3,990 suppliers and manufacturers in China. Thalys Group headquartered both in Wuhan and Shanghai, with more than 50 sales & service subsidiaries and 1,500 FTEs by the end of 2020. Thalys Group also commits to innovate on Life Science & Diagnostic technology by invested into several pioneering and innovative start-ups in single cell analysis and mRNA transcriptomic diagnostics.